Journal profile · Pharmacology & Pharmacy
European Journal of Drug Metabolism and Pharmacokinetics
ISSN 0378-7966 · eISSN 2107-0180 · Springer International Publishing · SWITZERLAND · Quarterly · Founded 1976
European Journal of Drug Metabolism and Pharmacokinetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.29; hybrid open access; APC about USD 2,690; median 129 days to acceptance (62 articles, last 24 months); community-reported acceptance: easy; 46 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Journal of Drug Metabolism and Pharmacokinetics is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Antibiotics Pharmacokinetics and Efficacy, together about 40.5% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
The European Journal of Drug Metabolism and Pharmacokinetics covers all aspects of pre-clinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy. The journal welcomes publications in the field of pharmacokinetic and pharmacodynamic modeling. Analytical methods validation linked with a pharmacokinetic study will also be considered. The journal publishes original research articles, short communications, review articles, leading articles, current opinion articles on special topics, and conference proceedings. Letters to the Editor are welcomed and will be considered for publication. All manuscripts are subject to peer review by international experts. The European Journal of Drug Metabolism and Pharmacokinetics publishes six issues a year.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 4 in mainland China (about 11%); most named United States 7, France 6, Mainland China 4, Germany 2, Italy 2 (35 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics17.8%
- Drug Transport and Resistance MechanismsMedicine13.1%
- Antibiotics Pharmacokinetics and EfficacyMedicine9.6%
- Analytical Methods in PharmaceuticalsChemistry5.2%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics5.1%
- Pharmacological Effects and Toxicity StudiesMedicine5%
- Analytical Chemistry and ChromatographyChemistry3.2%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.29LetPub ·
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.63LetPub ·
- SNIP 2026-06
- 0.79LetPub ·
- h-index
- 34LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 985OpenAlex ·
- 2-year mean citedness
- 1.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 29.41%LetPub ·
Volume
- Articles per year
- 42LetPub ·
- Downloads per year (publisher) 2025
- 242,100Publisher website ·
Articles by year OpenAlex count · 2,670 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 26 | 9 |
| 2025 | 46 | 18 | 85 |
| 2024 | 56 | 18 | 199 |
| 2023 | 62 | 19 | 532 |
| 2022 | 70 | 22 | 536 |
| 2021 | 78 | 35 | 964 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
129 daysMedian, submission to acceptance · P25–P75 94 days – 160 days
- Acceptance to online
- median 25 days (96 articles)
- Submission to online
- median 164 days
- Sample
- 62 articles with submission and acceptance dates (117 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,690 / EUR 4,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- 150–250 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted19
- brief communicationThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- brief communicationsReports of studies that are smaller in scale and, thus, may report pilot data warranting further investigation, may also be considered for publication; such art…Length not stated
- current opinionCurrent Opinion. Word count approximately up to 3000.Length not stated
- editorialInternal Review by Editorial Staff: The journal editor will perform an initial appraisal of each manuscript. When submitting your paper, please include a coveri…Length not stated
- editorial/commentaryEditorial/Commentary. Word count up to 1500.Length not stated
- leading articleLeading Article. Word count up to 4000.Length not stated
- letterThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- letter to the editorLetter to the Editor. Word count up to 1000.Length not stated
- opinionThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- original researchThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- original research articleThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- perspectiveThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- practical applicationPractical Application. Word count up to 3000.Length not stated
- research articleThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- research letterResearch Letter. Word count up to 1500.Length not stated
- reviewThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- review articleThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
- summary of research article (sra)Summary of Research Article (SRA): A standalone summary of a source article previously published in an Adis journal, or in a journal from another publisher.Length not stated
- systematic reviewThere is no limit on the number of tables, figures or references that can accompany an article. Information that is relevant but not critical to understanding t…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship Principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statement required for all original research Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- License & copyright Copyright and license term – CC BY-NC
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution-NonCommercial 4.0 International License Find more about the license agreement Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice articles use CC BY-NC 4.0, copyright stays with author Model summary
To find out more about publishing your work Open Access in European Journal of Drug Metabolism and Pharmacokinetics, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1976
- ISSN
- 0378-7966
- Electronic ISSN
- 2107-0180
- Latest issue on the website
- Volume 51, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Journal of Drug Metabolism and Pharmacokinetics
What CAS zone is European Journal of Drug Metabolism and Pharmacokinetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Drug Metabolism and Pharmacokinetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Drug Metabolism and Pharmacokinetics?
The latest impact factor listed by LetPub is 2.29; CiteScore 4.9, h-index 66.
How long does peer review take at European Journal of Drug Metabolism and Pharmacokinetics?
Based on the dates recorded on 62 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 129 days (interquartile range 94–160 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Drug Metabolism and Pharmacokinetics?
According to the journal's author guidelines: Abstract: 150–250 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Journal of Drug Metabolism and Pharmacokinetics based?
Of the 35 board members whose country the journal's board page names, 4 (about 11%) are in mainland China; the countries named most often are United States (7), France (6) and Mainland China (4). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Drug Metabolism and Pharmacokinetics?
According to LetPub and DOAJ records, European Journal of Drug Metabolism and Pharmacokinetics is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is European Journal of Drug Metabolism and Pharmacokinetics open access, and what is the APC?
European Journal of Drug Metabolism and Pharmacokinetics is a hybrid journal. For open-access publication: APC about USD 2,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .